Increased affinity leads to improved selective tumor delivery of single- chain Fv antibodies

Cancer Research

Volumn 58, Issue 3, 1998, Pages 485-490

  Adams, Gregory P ^a   Schier, Robert ^b   Marshall, Keith ^b   Wolf, Ellen J ^a   McCall, Adrian M ^a   Marks, James D ^b   Weiner, Louis M ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN G;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY AGENESIS; KIDNEY CLEARANCE; MOUSE; NONHUMAN; ONCOGENE NEU; OVARY CARCINOMA; PRIORITY JOURNAL; SCID MOUSE; SITE DIRECTED MUTAGENESIS; TUMOR LOCALIZATION;

EID: 0032006660     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sharkey, R. M., Gold, D. V., Aninipot, R., Vagg, R., Ballance, C., Newman, E. S., Ostella, F., Hansen, H. J., and Goldenberg, D. M. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens. Cancer Res., 50: 828s-834s, 1990.
2. Clauss, M. A., and Jain, R. K. Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues. Cancer Res., 50: 3487-3492, 1990.
3. Huston, J. S., Levinson, D., Mudgett, H. M., Tai, M. S., Novotny, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., Crea, R., and Oppermann, H. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA, 85: 5879-5883, 1988.
4. Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S. M., Lee, T., Pope, S. H., Riordan, G. S., and Whitlow, M. Single-chain antigen- binding proteins. [published erratum appears in Science (Washington DC), 244: 409, 1989], Science. 242: 423-426, 1988.
5. Adams, G. P., McCartney, J. E., Tai, M-S., Oppermann, H., Huston, J. S., Stafford, W. F., Bookman, M. A., Fand, I., Houston, L. L., and Weiner, L. M. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single chain Fv. Cancer Res., 53: 4026-4034, 1993.
6. Colcher, D., R., Bird, R., Roselli, M., Hardman, K. D., Johnson, S., Pope, S., Dodd, S. W., Pantoliano, M. W., Milenic, D. E., and Schlom, J. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J. Natl. Cancer Inst., 82: 1191-1197, 1990.
7. Milenic, D. E., Yokota, T., Filpula, D. R., Finkelman, M. A. J., Dodd, S. W., Wood, J. F., Whitlow, M., Snow, P., and Schlom, J. Construction, binding properties, metabolism, and targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res., 51: 6363-6371, 1991.
8. Yokota, T., Milenic, D., Whitlow, M., and Schlom, J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res., 52: 3402-3408, 1992.
9. Yokota, T., Milenic, D. E., Whitlow, M., Wood, J. F., Hubert, S. L., and Schlom, J. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Cancer Res., 53: 3776-3783, 1993.
10. Marks, J. D., Hoogenboom, H. R., Griffiths, A. D., and Winter, G. Molecular evolution of proteins on filamentous phage: mimicking the strategy of the immune system. J. Biol. Chem., 267: 16007-16010, 1992.
11. Marks, C., and Marks, J. D. Phage libraries: a new route to clinically useful antibodies. N. Engl. J. Med., 335: 730-733, 1996.
12. Schier, R., Marks, J. D., Wolf, E. J., Apell, G., Huston, J. S., Weiner, L. M., and Adams, G. P. In vitro and in vivo characterization of a human anti-c-erbB-2 single- chain Fv isolated from a filamentous phage antibody library. Immunotechnology, 1: 63-71, 1995.
13. Schier, R., McCall, A., Adams, G. P., Marshall, K., Yim, M., Merritt, H., Crawford, R. S., Weiner, L. M., Marks, C., and Marks, J. D. Isolation of picomolar affinity anti-c-erbB2 single-chain Fv by molecular evolution of the complementarity determining regions in the centre of the antibody combining site. J. Mol. Biol., 263: 551-567, 1996.
14. Marks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., and Winter, G. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol., 222, 581-597, 1991.
15. De Bellis, D., and Schwartz, I. Regulated expression of foreign genes fused to lac: control by glucose levels in growth medium. Nucleic Acids Res., 18: 1311, 1990.
16. Breitling, S. D., Seehaus, T., Klewinghaus, I., and Little, M. A surface expression vector for antibody screening. Gene (Amst.), 104: 147-153, 1991.
17. Hochuli, E., Bannwarth, W., Dobeli, H., Gentz, R., and Stuber, D. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology, 6: 1321-1325, 1988.
18. Weiner, L. M., Holmes, M., Richeson, A., Godwin, A., Adams, G. P., Hsieh-Ma, S. T., Ring, D. B., and Alpaugh, R. K. Binding and cytotoxicity characteristics of the bispecific murine monoclonal antibody 2B1. J. Immunol., 151: 2877-2886, 1993.
19. Adams, G. P., McCartney, J. E., Tai, M-S., Oppermann, H., Huston, J. S., Stafford, W. F., Bookman, M. A., Fand, I., Houston, L. L., and Weiner, L. M. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv. Cancer Res., 53: 4026-4034, 1993.
20. Meares, C. F., McCall, M. J., Reardan, D. T., Goodwin, D. A., Diamanti, P. I., and McTigue, M. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal. Biochem., 142: 68-78, 1984.
21. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
22. 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice. Cancer Res., 49: 1707-1711, 1989.
23. Fujimori, K., Covell, D. G., Fletcher, J. E., and Weinstein, J. N. A modeling analysis of monoclonal antibody percolation through tumors: a binding site barrier. J. Nucl. Med., 31: 1191-1198, 1990.
24. Juweid, M., Neumann, R., Paik, C., Perez-Bacete, M. J., Sato, J., van Osdol, W., and Weinstein, J. N. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res., 52: 5144-5153, 1992.
25. Colcher, D., Minelli, F. M., Roselli, M., Muraro, R., Simpson-Milenic, D., and Schlom, J. Radioimmmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies. Cancer Res., 48: 4597-4603, 1988.
26. Gallinger, S., Reilly, R. M., Kirsh, J. C., Odze, R. D., Schmocker, B. J., Hay, K., Polihronis, J., Damani, M. T., Shpitz, B., and Stern, H. S. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients. Cancer Res., 53: 271-278, 1993.
27. Weiner, L. M., Houston, L. L., Huston, J. S., McCartney, J. E., Tai, M-S., Apell, G., Stafford, W. F., Bookman, M. A., Gallo, J. M., and Adams, G. P. Improving the tumor-selective delivery of single-chain Fv molecules. Tumor Targeting, 1: 51-60, 1995.
28. Huston, J. S., George, A. J. T., Adams, G. P., Stafford, W. F., Jamar, F., Tai, M-S., McCartney, J. E., Oppermann, H., Heelan, B. T., Peters, A. M., Houston, L. L., Bookman, M. A., Wolf, E. J., and Weiner, L. M. Single-chain Fv radioimmunotargeting. Q. J. Nucl. Med., 40: 320-333, 1996.
29. Weiner, L. M., Houston, L. L., Huston, J. S., McCartney, J. E., Tai, M-S., Apell, G., Stafford, W. F., Bookman, M. A., Gallo, J. M., and Adams, G. P. Improving the tumor-selective delivery of single-chain Fv molecules. Tumor Targeting, 1: 51-60, 1995.
30. Buchegger, F., Halpern, S. E., Sutherland, R. M., Schreyer, M., and Mach, J-P. In vitro and in vivo tumor models for studies of distribution of radiolabeled monoclonal antibodies and fragments. Nuklearmedizin, 25: 207-209, 1986.
31. 2, an anti-c-erbB-2 single-chain Fv dimer, mediated by stable radioiodinc conjugation. J. Nucl. Med., 36: 2276-2281, 1995.